Lisa M Holle

12PUBLICATIONS
13CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEducational technology and computingWork integrated learning (incl. internships)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 11, 2025
Lutetium Lu 177 vipivotide tetraxetan: A literature review.

Grace Morrison, Lisa M Holle

|May 13, 2025
Improved oral anticancer medication (OAM) adherence/toxicity assessment documentation: A quality improvement initiative.

Lisa M Holle, Andrea Moran, Margaret Savage

|Oct 22, 2024
Falls and fractures in men with prostate cancer taking second-generation androgen receptor antagonists: A retrospective chart review.

Morgan Dennison, Lisa Holle

|Feb 25, 2023
Updates in the Treatment of Non-Metastatic Castrate-Resistant Prostate Cancer: The Benefit of Second-Generation Androgen Receptor Antagonists.

Matthew J Hadfield, Vikram Lyall, Lisa M Holle

|Feb 24, 2023
Expansion of MyDispense: A Descriptive Report of Simulation Activities and Assessment in a Certified Pharmacy Technician Training Program.

Cassandra R Doyno, Lisa M Holle, Renee Puente

|May 24, 2021
International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care.

Lisa M Holle, Tegan Bilse, Ramatu Masud Alabelewe

Pageof 2

Frequent Collaborators

1 joint publications

Morgan Dennison

1 joint publications

Jill Bates

1 joint publications

Diana M Sobieraj

1 joint publications

Esin Aysel Kandemir